(Newcastle Upon Tyne, 11th June 2025) The Kuraray Life Innovation Business Promotion Department, a division of Kuraray Co., Ltd. (TYO: 3406), a global leader in specialty chemicals, and Cellularevolution Ltd. (CellRev), an innovative developer of bioprocessing media additives, have entered into a strategic partnership aimed at enhancing cell culture solutions within the mesenchymal stem cells …
In the race to make vaccines faster, cheaper, and more equitably distributed, one challenge has quietly dragged behind the spotlight: upstream bioprocess inefficiencies. These early-stage production bottlenecks are where promising vaccine candidates either scale into commercial success or fizzle into sunk costs. And yet, despite their impact, upstream processes are often treated as rigid frameworks—something …
Why upstream bioprocess inefficiencies are the Vaccine industry’s silent saboteur Read More »
Cell-to-cell adhesion of mammalian cells is what cells are supposed to do, but can be quite detrimental to bioprocessing, upstream and downstream, by producing cell clumps with later formation of larger clusters. Single cell suspensions, microcarrier-adherent cells and stem cell aggregates demonstrate this behaviour. How do we prevent something natural from occurring? The typical workaround …
CellRev launches its proprietary media additive AggreGuard™ which prevents aggregation of adherent cells and increases cell yield in existing VERO processes CellRev, the bioprocessing company revolutionising continuous mammalian cell manufacturing, has launched its proprietary media additive AggreGuard™ to prevent the aggregation of microcarrier-supported cells in adherent cell culture. AggreGuard™ is a mixture of enzymes that …
CellRev Launches Its Proprietary Media Additive, AggreGuard™ Read More »
Technology
About Us
Join our mailing list
